Cancers (Sep 2020)

Senescent Tumor CD8<sup>+</sup> T Cells: Mechanisms of Induction and Challenges to Immunotherapy

  • Wei Liu,
  • Paweł Stachura,
  • Haifeng C. Xu,
  • Sanil Bhatia,
  • Arndt Borkhardt,
  • Philipp A. Lang,
  • Aleksandra A. Pandyra

DOI
https://doi.org/10.3390/cancers12102828
Journal volume & issue
Vol. 12, no. 10
p. 2828

Abstract

Read online

The inability of tumor-infiltrating T lymphocytes to eradicate tumor cells within the tumor microenvironment (TME) is a major obstacle to successful immunotherapeutic treatments. Understanding the immunosuppressive mechanisms within the TME is paramount to overcoming these obstacles. T cell senescence is a critical dysfunctional state present in the TME that differs from T cell exhaustion currently targeted by many immunotherapies. This review focuses on the physiological, molecular, metabolic and cellular processes that drive CD8+ T cell senescence. Evidence showing that senescent T cells hinder immunotherapies is discussed, as are therapeutic options to reverse T cell senescence.

Keywords